首页> 外文OA文献 >Secondary EML4–ALK-positive Lung Adenocarcinoma in a Patient Previously Treated for Acute Lymphoblastic Leukemia in Childhood: A Case Reportated for Acute Lymphoblastic Leukemia in Childhood: A Case Report
【2h】

Secondary EML4–ALK-positive Lung Adenocarcinoma in a Patient Previously Treated for Acute Lymphoblastic Leukemia in Childhood: A Case Reportated for Acute Lymphoblastic Leukemia in Childhood: A Case Report

机译:先前治疗儿童急性淋巴细胞白血病患者的继发性EmL4-aLK阳性肺腺癌:儿童急性淋巴细胞白血病报告病例报告

摘要

It is widely recognized that the risk of secondary neoplasms increases as childhood cancer survivors progress through adulthood. These are mainly hematological malignancies, and recurrent chromosome translocations are commonly detected in such cases. On the other hand, while secondary epithelial malignancies have sometimes been reported, chromosome translocations in these epithelial malignancies have not. A 33-year-old man who had been diagnosed with acute lymphoblastic leukemia and treated with chemotherapy almost 20 years earlier was diagnosed with lung adenocarcinoma. After chromosomal rearrangement of echinoderm microtubule- associated protein-like 4 gene and the anaplastic lymphoma kinase gene was detected in this adenocarcinoma, he responded to treatment with crizotinib. It was therefore concluded that this echinoderm microtubule-associated protein-like 4 gene-anaplastic lymphoma kinase gene-positive lung adenocarcinoma was a secondary epithelial malignancy.
机译:众所周知,随着成年期儿童癌症幸存者的发展,继发性肿瘤的风险会增加。这些主要是血液系统恶性肿瘤,在这种情况下通常检测到复发性染色体易位。另一方面,尽管有时已报告继发性上皮恶性肿瘤,但这些上皮恶性肿瘤中的染色体易位却没有。一名33岁的男子被诊断出患有急性淋巴细胞白血病,并在将近20年前接受了化学疗法的治疗,被诊断出患有肺腺癌。在该腺癌中检测到棘皮动物微管相关蛋白样4基因和间变性淋巴瘤激酶基因的染色体重排后,他对克唑替尼进行了治疗。因此,可以得出结论,该棘皮动物微管相关蛋白样4基因-间变性淋巴瘤激酶基因阳性的肺腺癌是继发性上皮恶性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号